Doctor profile · Federal record
Dr. MARK TESTA, DO
Family Medicine Physician (CMS: FAMILY PRACTICE) · Family Medicine Physician · PHILADELPHIA, PA
- NPI 1043205370
- Accepts Medicare
- MIPS 27.0 / 100 · 2023
- 37 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2601 S 12TH ST
PHILADELPHIA, PA 191484303
(215) 389-6461
fax (215) 389-3726 - Mailing address
-
1332 W RITNER ST
PHILADELPHIA, PA 191483537
Credentials & registration
- NPI registered
- September 2005 — 21 yrs on file
- Profile last updated
- February 27, 2020
- Year of graduation
- 1989 — 37 yrs since
- Specialty taxonomy
- 207Q00000X — NUCC code
- State licenses (2)
- Pennsylvania #0S007357C · New Jersey #25MB06014000
- Medicaid
- PA #0012858720001
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1043205370. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
3,969
Distinct HCPCS
10
Medicare allowed
$367,796
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 1,084 | 455 | $134 | |
99458 |
Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 807 | 63 | $42 | |
99457 |
Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 609 | 67 | $52 | |
99349 |
Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | 576 | 76 | $134 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 343 | 162 | $96 | |
99454 |
Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 302 | 51 | $54 | |
G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 93 | 93 | $136 | |
99497 |
Advance care planning, first 30 minutes | 60 | 60 | $87 | |
G0444 |
Annual depression screening, 5 to 15 minutes | 31 | 31 | $19 | |
99350 |
Residence visit for established patient with high level of medical decision making, per day, if using time, at least 60 minutes | 28 | 28 | $195 |
In context: peer comparison
Among 166 peers in this city , average services per provider: 84. This provider delivers 47× the peer median.Open Payments
Industry payments received
All-time total
$2,527
Transactions
102
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $406.73 | |
| ABBVIE INC. | 22 | $389.68 | |
| Otsuka America Pharmaceutical, Inc. | 11 | $212.09 | |
| Lilly USA, LLC | 10 | $174.52 | |
| Novo Nordisk Inc | 9 | $171.59 | |
| GlaxoSmithKline, LLC. | 12 | $155.89 | |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $101.58 | |
| Axsome Therapeutics, Inc. | 3 | $79.34 | |
| Neurocrine Biosciences, Inc. | 3 | $75.40 | |
| PFIZER INC. | 4 | $65.83 | |
| Teva Pharmaceuticals USA, Inc. | 4 | $61.73 | |
| Astellas Pharma US Inc | 3 | $60.11 | |
| Amgen Inc. | 3 | $58.14 | |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $56.46 | |
| SHIELD THERAPEUTICS INC | 1 | $47.84 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
7,777
Patients
1,926
Total drug cost
$119,402
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Rosuvastatin Calcium | Generic | 1,085 | 261 | $24,615 |
| Atorvastatin Calcium | Generic | 737 | 196 | $10,326 |
| Amlodipine Besylate | Generic | 648 | 166 | $3,963 |
| Alprazolam | Generic | 554 | 97 | $5,519 |
| Levothyroxine Sodium | Generic | 534 | 133 | $10,129 |
| Lisinopril | Generic | 527 | 133 | $4,378 |
| Gabapentin | Generic | 513 | 110 | $7,648 |
| Omeprazole | Generic | 479 | 130 | $6,392 |
| Losartan Potassium | Generic | 464 | 117 | $6,375 |
| Pantoprazole Sodium | Generic | 412 | 105 | $6,716 |